Somatostatin
OtherResearch use only
Educational use only. Not medical advice. Verify all information with primary sources and a licensed clinician before use.
Body Map
Overview
Somatostatin binds to somatostatin receptors (SSTR1-5), inhibiting adenylate cyclase and reducing cAMP levels, which suppresses hormone secretion. FDA approved synthetic analogs (octreotide, lanreotide) are available for acromegaly and neuroendocrine tumors.
Primary Uses
Growth Hormone Suppression
Insulin Suppression
Glucagon Suppression
TSH Suppression
Acromegaly
Neuroendocrine tumors
Protocol Reference
Evidence
FDA approved synthetic analogs
Also in Other